Finch Therapeutics Group IncChange company Symbol lookupSelect an option...FNCH Finch Therapeutics Group IncTDY Teledyne Technologies IncTGS Transportadora de Gas del Sur SALPRO Open Lending CorpSLGL Sol Gel Technologies LtdUAVS Ageagle Aerial Systems IncIWSY ImageWare Systems IncAMPX Amprius Technologies IncTNC Tennant CoCVX Chevron CorpGo
*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Finch Therapeutics Group, Inc. is a microbiome technology company with a portfolio of intellectual property and microbiome assets. It is focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations. It has an intellectual property estate, including more than 70 issued U.S. and foreign patents with relevance for both donor-derived and donor-independent microbiome therapeutics in a range of potential indications. The Company’s assets include CP101, an orally administered microbiome candidate designed for the prevention of recurrent C. difficile infection (CDI), with positive clinical data from a Phase II randomized, placebo-controlled trial and a Phase II open-label trial, and pre-clinical assets that are designed to target ulcerative colitis, Crohn’s disease, and autism spectrum disorder. Additionally, it has also developed a biorepository of strains and samples.
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| May 10, 2023 | Q1 2023 Earnings Release | -$0.38 | -$0.09 to -$0.09 | -- |
| March 23, 2023 | Q4 2022 Earnings Release | -$0.56 | -$0.34 to -$0.34 | -$0.40 |
| November 10, 2022 | Q3 2022 Earnings Release | -$0.85 | -$0.42 to -$0.38 | -$0.21 |
| August 11, 2022 | Q2 2022 Earnings Release | -$0.48 | -$0.46 to -$0.37 | -$0.32 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.